Newsletters

Q2 2021 Excelsior Newsletter

Dispense As Written Prescription Instructions and Their Impact on Plan Sponsors and Participants by Joe Schmidt, MBA, Vice President | Team Lead   Before the

Read More »

Q1 2021 Excelsior Newsletter

Common Sense Management of Narcolepsy and Cataplexy by Bob Kordella, R.Ph., MBA, Chief Clinical Officer  The Mayo Clinic provides a simple definition of narcolepsy and

Read More »

ICER Update 01.22.21

Hello, everyone, and welcome to this edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER has published its latest report on

Read More »

Q4 2020 Excelsior Newsletter

November 30, 2020:Where We Are Today And When Will New Vaccines Be Approved? by Bob Kordella, R.Ph., MBA, Chief Clinical Officer Worldwide there were 48

Read More »

ICER Update 10.30.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER has posted a Draft Scoping

Read More »

ICER Update 10.19.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a Final Evidence Report

Read More »

Q3 2020 Excelsior Newsletter

COVID-19 Vaccine Update by Bob Kordella, R.Ph., MBA, Chief Clinical Officer As several COVID-19 vaccine candidates work their way through the clinical trials process, many

Read More »

ICER Update 10.05.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a Final Evidence Report

Read More »

ICER Update 04.27.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER unexpectedly released an Evidence Report

Read More »
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on whatsapp